[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fC8HnUCveiUTJ5kwPDPs8X7YWasonrYDn-Hgvu8homrU":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":31,"phaseBuckets":37,"rows":44},"Azienda Ospedaliera di Padova",[4],37,false,10,2,12260,1,24,[14,17,19,21,23,25,27,29],{"name":15,"count":16},"Sedation Complication",3,{"name":18,"count":9},"Acute Kidney Injury",{"name":20,"count":9},"Liver Failure",{"name":22,"count":9},"Liver Diseases",{"name":24,"count":9},"Liver Neoplasms",{"name":26,"count":9},"Liver Cirrhosis",{"name":28,"count":11},"Procedural Sedation",{"name":30,"count":11},"Behavior Disorders",[32],{"nctId":33,"briefTitle":34,"date":35,"intervention":36},"NCT07392229","Zanubritnib and Anti-MAG Neuropathy","2031-03","Zanubrutinib Oral",[38,39,40,41,42,43],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[45,68,99,126,144,171,189,215,241,265,310,337,363],{"intervention":36,"totalTrials":11,"cells":46},{"EARLY_PHASE1":47,"PHASE1":50,"PHASE2":52,"PHASE3":62,"PHASE4":64,"NA":66},{"trials":48,"activeCount":49},[],0,{"trials":51,"activeCount":49},[],{"trials":53,"activeCount":11,"soonestReadout":35},[54],{"nctId":33,"briefTitle":34,"status":55,"phases":56,"primaryCompletion":35,"completion":35,"start":57,"enrollment":58,"conditions":59,"interventions":61},"RECRUITING",[40],"2026-03-24",50,[60],"Anti-MAG IgM-associated Demyelinating Polyneuropathy",[36],{"trials":63,"activeCount":49},[],{"trials":65,"activeCount":49},[],{"trials":67,"activeCount":49},[],{"intervention":69,"totalTrials":11,"cells":70},"peginterferon plus ribavirin",{"EARLY_PHASE1":71,"PHASE1":73,"PHASE2":75,"PHASE3":77,"PHASE4":79,"NA":97},{"trials":72,"activeCount":49},[],{"trials":74,"activeCount":49},[],{"trials":76,"activeCount":49},[],{"trials":78,"activeCount":49},[],{"trials":80,"activeCount":49},[81],{"nctId":82,"briefTitle":83,"status":84,"phases":85,"primaryCompletion":86,"completion":87,"start":88,"enrollment":89,"conditions":90,"interventions":96},"NCT01195181","Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice.","COMPLETED",[42],"2009-12","2010-08","2005-09",506,[91,92,93,94,95],"Hepatitis C Virus","Chronic Liver Disease","Viral Hepatitis","Therapeutic Uses","Antiviral Agents",[69],{"trials":98,"activeCount":49},[],{"intervention":100,"totalTrials":11,"cells":101},"Cisatracurium",{"EARLY_PHASE1":102,"PHASE1":104,"PHASE2":106,"PHASE3":108,"PHASE4":110,"NA":124},{"trials":103,"activeCount":49},[],{"trials":105,"activeCount":49},[],{"trials":107,"activeCount":49},[],{"trials":109,"activeCount":49},[],{"trials":111,"activeCount":49},[112],{"nctId":113,"briefTitle":114,"status":84,"phases":115,"primaryCompletion":116,"completion":116,"start":117,"enrollment":118,"conditions":119,"interventions":122},"NCT01651572","Comparison Between Cisatracurium and Rocuronium in Terms of Recovery of the Muscular Strength in the Postoperative Phase After Surgery and General Anaesthesia",[42],"2013-07","2012-07",120,[120,121],"Postoperative Residual Curarization","Residual Neuromuscular Block",[100,123],"Rocuronium",{"trials":125,"activeCount":49},[],{"intervention":123,"totalTrials":11,"cells":127},{"EARLY_PHASE1":128,"PHASE1":130,"PHASE2":132,"PHASE3":134,"PHASE4":136,"NA":142},{"trials":129,"activeCount":49},[],{"trials":131,"activeCount":49},[],{"trials":133,"activeCount":49},[],{"trials":135,"activeCount":49},[],{"trials":137,"activeCount":49},[138],{"nctId":113,"briefTitle":114,"status":84,"phases":139,"primaryCompletion":116,"completion":116,"start":117,"enrollment":118,"conditions":140,"interventions":141},[42],[120,121],[100,123],{"trials":143,"activeCount":49},[],{"intervention":145,"totalTrials":11,"cells":146},"Urokinase and Dornase alfa",{"EARLY_PHASE1":147,"PHASE1":149,"PHASE2":151,"PHASE3":153,"PHASE4":167,"NA":169},{"trials":148,"activeCount":49},[],{"trials":150,"activeCount":49},[],{"trials":152,"activeCount":49},[],{"trials":154,"activeCount":49},[155],{"nctId":156,"briefTitle":157,"status":158,"phases":159,"completion":160,"start":161,"enrollment":162,"conditions":163,"interventions":165},"NCT00502632","Dornase Alfa and Urokinase for Kids With Pleural Empyema","UNKNOWN",[40,41],"2009-10","2007-10",94,[164],"Pleural Empyema",[145,166],"Urokinase",{"trials":168,"activeCount":49},[],{"trials":170,"activeCount":49},[],{"intervention":166,"totalTrials":11,"cells":172},{"EARLY_PHASE1":173,"PHASE1":175,"PHASE2":177,"PHASE3":179,"PHASE4":185,"NA":187},{"trials":174,"activeCount":49},[],{"trials":176,"activeCount":49},[],{"trials":178,"activeCount":49},[],{"trials":180,"activeCount":49},[181],{"nctId":156,"briefTitle":157,"status":158,"phases":182,"completion":160,"start":161,"enrollment":162,"conditions":183,"interventions":184},[40,41],[164],[145,166],{"trials":186,"activeCount":49},[],{"trials":188,"activeCount":49},[],{"intervention":190,"totalTrials":11,"cells":191},"Caspofungin",{"EARLY_PHASE1":192,"PHASE1":194,"PHASE2":196,"PHASE3":209,"PHASE4":211,"NA":213},{"trials":193,"activeCount":49},[],{"trials":195,"activeCount":49},[],{"trials":197,"activeCount":49},[198],{"nctId":199,"briefTitle":200,"status":158,"phases":201,"primaryCompletion":202,"completion":202,"start":203,"enrollment":204,"conditions":205,"interventions":208},"NCT01260974","Caspofungin as Prophylaxis in High Risk Liver Transplantation Recipients",[40],"2012-11","2009-05",38,[206,207],"Fungemia","Mycoses",[190],{"trials":210,"activeCount":49},[],{"trials":212,"activeCount":49},[],{"trials":214,"activeCount":49},[],{"intervention":216,"totalTrials":11,"cells":217},"N-acetylcystein",{"EARLY_PHASE1":218,"PHASE1":220,"PHASE2":222,"PHASE3":235,"PHASE4":237,"NA":239},{"trials":219,"activeCount":49},[],{"trials":221,"activeCount":49},[],{"trials":223,"activeCount":49},[224],{"nctId":225,"briefTitle":226,"status":84,"phases":227,"primaryCompletion":228,"completion":228,"start":229,"enrollment":230,"conditions":231,"interventions":234},"NCT01394497","Use of N-Acetylcysteine During Liver Procurement",[40],"2009-07","2006-12",140,[20,232,22,233,24],"Liver Failure, Acute","Carcinoma, Hepatocellular",[216],{"trials":236,"activeCount":49},[],{"trials":238,"activeCount":49},[],{"trials":240,"activeCount":49},[],{"intervention":242,"totalTrials":11,"cells":243},"Everolimus",{"EARLY_PHASE1":244,"PHASE1":246,"PHASE2":248,"PHASE3":259,"PHASE4":261,"NA":263},{"trials":245,"activeCount":49},[],{"trials":247,"activeCount":49},[],{"trials":249,"activeCount":49},[250],{"nctId":251,"briefTitle":252,"status":158,"phases":253,"primaryCompletion":254,"completion":254,"start":255,"enrollment":256,"conditions":257,"interventions":258},"NCT01423708","Everolimus in de Novo Liver Transplantation: a Multicentre Randomized Study",[40],"2014-01","2010-02",117,[20,22,26,24],[242],{"trials":260,"activeCount":49},[],{"trials":262,"activeCount":49},[],{"trials":264,"activeCount":49},[],{"intervention":266,"totalTrials":16,"cells":267},"dexmedetomidine",{"EARLY_PHASE1":268,"PHASE1":270,"PHASE2":272,"PHASE3":284,"PHASE4":286,"NA":288},{"trials":269,"activeCount":49},[],{"trials":271,"activeCount":49},[],{"trials":273,"activeCount":49},[274],{"nctId":275,"briefTitle":276,"status":84,"phases":277,"primaryCompletion":278,"completion":279,"start":280,"enrollment":281,"conditions":282,"interventions":283},"NCT03799783","The Use of Dexmedetomidine for EEG Sedation in Children With Behavioural Disorders",[40],"2019-02-28","2019-09-28","2018-03-01",19,[28,30],[266],{"trials":285,"activeCount":49},[],{"trials":287,"activeCount":49},[],{"trials":289,"activeCount":49},[290,299],{"nctId":291,"briefTitle":292,"status":84,"phases":293,"primaryCompletion":294,"completion":295,"start":280,"enrollment":296,"conditions":297,"interventions":298},"NCT06434428","Comparison Between Intranasal vs Intravenous Dexmedetomidine for EEG Sedation of Children With Behavior Disorders.",[],"2021-08-30","2022-09-30",48,[15],[266,266],{"nctId":300,"briefTitle":301,"status":84,"phases":302,"primaryCompletion":303,"completion":303,"start":304,"enrollment":305,"conditions":306,"interventions":308},"NCT03760978","Dexmedetomidine for Prolonged Sedation in PICUs",[],"2018-12-31","2016-01-01",163,[307],"Prolonged Sedation",[309],"Dexmedetomidine",{"intervention":311,"totalTrials":11,"cells":312},"Chemotherapy",{"EARLY_PHASE1":313,"PHASE1":315,"PHASE2":317,"PHASE3":319,"PHASE4":321,"NA":323},{"trials":314,"activeCount":49},[],{"trials":316,"activeCount":49},[],{"trials":318,"activeCount":49},[],{"trials":320,"activeCount":49},[],{"trials":322,"activeCount":49},[],{"trials":324,"activeCount":49},[325],{"nctId":326,"briefTitle":327,"status":158,"phases":328,"primaryCompletion":329,"completion":329,"start":330,"enrollment":331,"conditions":332,"interventions":336},"NCT04870879","Colorectal Metastasis and Liver Transplantation With Organs From Deceased Donors",[43],"2025-10","2020-10-01",18,[333,334,335],"Colorectal Liver Metastases","Colorectal Adenocarcinoma","Unresectable Malignant Neoplasm",[311],{"intervention":338,"totalTrials":11,"cells":339},"Crystalloids, albumin, vasoconstrictors, diuretics, renal replacement therapy",{"EARLY_PHASE1":340,"PHASE1":342,"PHASE2":344,"PHASE3":346,"PHASE4":348,"NA":350},{"trials":341,"activeCount":49},[],{"trials":343,"activeCount":49},[],{"trials":345,"activeCount":49},[],{"trials":347,"activeCount":49},[],{"trials":349,"activeCount":49},[],{"trials":351,"activeCount":49},[352],{"nctId":353,"briefTitle":354,"status":84,"phases":355,"primaryCompletion":356,"completion":357,"start":358,"enrollment":359,"conditions":360,"interventions":362},"NCT05387811","International Registry of Acute Kidney Injury in Cirrhosis: The GLOBAL AKI Project",[],"2023-09-30","2023-11-30","2022-07-01",1456,[26,18,361],"Hepatorenal Syndrome",[338],{"intervention":364,"totalTrials":11,"cells":365},"Capecitabine",{"EARLY_PHASE1":366,"PHASE1":368,"PHASE2":370,"PHASE3":372,"PHASE4":374,"NA":376},{"trials":367,"activeCount":49},[],{"trials":369,"activeCount":49},[],{"trials":371,"activeCount":49},[],{"trials":373,"activeCount":49},[],{"trials":375,"activeCount":49},[],{"trials":377,"activeCount":49},[378],{"nctId":379,"briefTitle":380,"status":158,"phases":381,"primaryCompletion":116,"start":382,"enrollment":383,"conditions":384,"interventions":387},"NCT01549795","Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy",[43],"2012-01",33,[385,386],"Hilar Cholangiocarcinoma","Primary Sclerosing Cholangitis",[364]]